K E Y W O R D S: precision medicine, biobanking, public engagement, valuesbased regulation We are pleased to be given the opportunity to read and respond to the peer commentaries on our 'regulatory soup' essay 1 by Bartha Knoppers 2 and Shawn Harmon. 3 Knoppers frames her response as a dichotomy between regulation and collaboration, and emphasizes the role of patient/participant/public engagement as the key to ensuring that precision medicine and its associated infrastructure operates

more »

... ely. In contrast, Harmon focuses on regulatory tools that may be employed to ensure that 'innovations are timely, widely affordable, safe, and effective'. In particular, he draws attention to the † Professor of Law, Director of the Centre for Law and Genetics, University of Tasmania. The broad theme of Dianne's research is the regulation of biotechnology and human genomics and genetics. She is particularly interested in the commercialization of genetic knowledge and patenting of genetic inventions, as well as the specific regulatory issues associated with genetic, genomic, cloning and stem cell technologies, and biobanking.